-
BRD4–RAC1 Co-targeting in Breast Cancer
2026-08-30
The 2021 International Journal of Biological Sciences study shows that simultaneous inhibition of BET bromodomain BRD4 and RAC1 suppresses growth, stemness, migration, and xenograft tumorigenesis across breast cancer subtypes. Its mechanistic contribution is to connect BRD4–RAC1 inhibition with disruption of the c-MYC–G9a–FTH1 axis and downregulation of HDAC1, providing a rationale for combination rather than single-pathway targeting.
-
PPARG R212W in Familial Partial Lipodystrophy Type 3
2026-08-29
This 2026 study links the PPARG R212W variant to familial partial lipodystrophy type 3 through reduced receptor activity, accelerated protein degradation, mitochondrial dysfunction, and impaired adipocyte gene expression. Partial rescue by rosiglitazone supports ligand-based functional testing while highlighting the need to distinguish molecular rescue from clinical efficacy.
-
Verapamil Targets TXNIP in Osteoporosis Research
2026-08-28
A 2025 Journal of Orthopaedic Translation study identifies TXNIP as a mechanistic link between verapamil exposure and reduced bone loss in ovariectomized mice. By combining human genetic association data, cell-based assays, transcriptomics, and in vivo imaging, the work supports further investigation of verapamil-driven regulation of osteoclast and osteoblast activity while leaving clinical efficacy and dosing unresolved.
-
MK-571: From Leukotrienes to Drug Resistance
2026-08-28
MK-571 (L-660,711) offers a strategically valuable way to separate cysteinyl leukotriene signaling from ABCC1/MRP1-associated drug transport. This thought-leadership guide connects pulmonary inflammation models with macrophage protection studies and outlines a disciplined path for translational assay design.
-
SB 202190: p38 MAP Kinase Inhibitor Workflows
2026-08-27
Use SB 202190 to interrogate p38α/β signaling in inflammation research, cancer therapeutics research, and organoid–immune co-cultures. This guide translates the CRC organoid–Treg reference model into a practical perturbation workflow with dosing, controls, troubleshooting, and assay-selection guidance.
-
(-)-Epigallocatechin Gallate (EGCG) Workflows
2026-08-27
Build more reproducible apoptosis, antiangiogenesis, cancer chemoprevention, and infection assays with a concentration- and stability-aware EGCG workflow. The 2024 reference study also shows why native EGCG should be benchmarked against improved analogs when intracellular pathogen clearance is the experimental endpoint.
-
HyperScript™ RT SuperMix for qPCR: Lab Scenarios
2026-08-26
A scenario-based guide to selecting and applying HyperScript™ RT SuperMix for qPCR (SKU K1074) when cell viability, proliferation, and cytotoxicity studies require dependable gene expression data. It connects reverse-transcription design, low-input RNA handling, protocol control, and interpretation of qRT-PCR results to cancer-cell assay workflows and published biomarker research.
-
3-Bromopyruvate Reverses Cetuximab Resistance
2026-08-26
Mu et al. show that combining 3-bromopyruvate with cetuximab suppresses cetuximab-resistant colorectal cancer cells through coordinated ferroptosis, autophagy, and apoptosis. The study links this response to restoration of FOXO3a activity, providing a mechanistic framework for testing combination treatments in genetically diverse resistance models.
-
LPS Protection of Macrophages During Chemotherapy
2026-08-25
This study identifies system Xc−-dependent glutathione synthesis and ABCC1-associated transport as contributors to lipopolysaccharide-mediated protection of macrophages from antitumor drug injury. Its design separates canonical LPS receptor signaling from redox and transporter mechanisms, offering a framework for studying selective immune-cell protection during chemotherapy.
-
Tobramycin: From MIC Data to Assay Design
2026-08-25
Explore how Tobramycin’s 30S-ribosome activity and classic clinical-isolate data can guide modern assay design. This evidence-focused perspective distinguishes MIC measurement from mechanistic inference and supports rigorous antibiotic resistance research.
-
Doxorubicin (Adriamycin) HCl: Assay Guide
2026-08-24
This scenario-based guide helps researchers select concentrations, control solvent and storage variables, interpret cytotoxicity and apoptosis data, and extend doxorubicin experiments to cardiotoxicity models. It explains how Doxorubicin (Adriamycin) HCl, SKU A1832, supports more defensible workflows through defined chemical identity, documented solubility, and practical handling guidance.
-
Thiothixene for Macrophage Efferocytosis Research
2026-08-24
Thiothixene extends beyond its role as a typical antipsychotic agent by providing a practical probe for macrophage efferocytosis, Arginase 1 induction, and dopamine-linked immune regulation. This guide translates the reference findings into assay-ready workflows, controls, optimization points, and translational guardrails.
-
D-Luciferin Sodium Salt for CAR-M Imaging
2026-08-23
D-Luciferin sodium salt enables a practical firefly luciferase readout for tracking tumor burden, reporter expression, and cellular energy in CAR-macrophage studies. This guide connects substrate preparation and imaging optimization with the mRNA-LNP programming strategy described in the reference study, while distinguishing photon output from definitive immune-function measurements.
-
Diminazene Aceturate: Mechanism and Research Use
2026-08-22
Diminazene Aceturate is a di-amidine trypanocidal research compound with high reported solubility in DMSO and water. A mouse sepsis study also evaluated it as an ACE2 activator linked to MasR–Sirt1 signaling and mitochondrial biogenesis, but that cardiovascular evidence does not establish a universal mechanism across parasite models.
-
Hexose Diphosphate: From Flux to Inflammation
2026-08-22
Hexose diphosphate is more than a glycolytic intermediate: it is a useful entry point for separating metabolic flux, energy homeostasis, and inflammatory signaling. This article presents an identity-first assay strategy informed by new PEP–cGAS research without conflating distinct metabolites.